FindTrial
Sign In

An observational study of individualized drug sensitivity testing in tumor organoids

An observational study of individualized drug sensitivity testing in tumor organoids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102590
Enrollment
Unknown
Registered
2025-05-16
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

Observation group:Observational study, without intervention

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged over 18 years. 2. Pathologically confirmed diagnosis of malignant tumor. 3. Availability of fresh tumor tissue or malignant fluid. 4. Voluntary participation in this clinical trial, understanding and compliance with study procedures, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Inability to obtain sufficient fresh tumor tissue or malignant fluid through surgery, biopsy, or puncture. 2. Currently receiving other treatments that may affect the study. 3. Pregnant patients. 4. Subjects with incapacity/limited capacity. 5. Cognitive impairment. 6. Other situations deemed by the researcher as unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Success rate of tumor organoid modeling;—

Secondary

MeasureTime frame
IC50;Genotyping;—

Countries

China

Contacts

Public ContactYingyong Hou

Zhongshan Hospital, Fudan University

houyingyong@aliyun.com+86 136 8197 2385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026